Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Introducing an Advanced System for Real-Time Chemotaxis Research

By LabMedica International staff writers
Posted on 13 Oct 2010
A new high throughput solution for chemotaxis research has been created by combining an automated microplate cytometer with an advanced microconduit array system.

The advanced approach for living cell analysis comprises the TTP LabTech (Cambridge, United Kingdom) Acumen eX3 microplate cytometer and the BellBrooks Labs (Madison, WI, USA) "iuvo” Chemotaxis Assay Plate.

The Acumen eX3 performs cell-based screening using up to three lasers (at 405, 488, and 633 nm) and simultaneous four color detection for each laser to provide content-rich data. More...
This enables a wide range of fluorescent reagents to be combined in multicolor, multiplexed assays. Nonetheless, data file sizes are significantly smaller than those generated by high content imaging technologies are. With an achievable throughput of over 300,000 wells per day, the Acumen eX3 has become an enabling platform for many high content screening organizations.

The "iuvo” Chemotaxis Assay Plate is a high content, automation friendly microconduit array plate that facilitates horizontal chemotaxis in the presence of a defined gradient. Three-dimensional cell culture is easy to carry out, and the entire compartment is accessible to microscope-based instruments as well as plate scanners. The microchannel environment reduces dilution of secreted signaling molecules, and the media can be sampled for analysis of secreted factors.

Dr. Paul Wylie, Acumen product manager at TTP LabTech, said, "This has proved a successful combination of products for customers involved with chemotaxis as the Acumen eX3 and ”iuvo” plates offer an efficient alternative to the more traditional microscopy set-up requiring further off-line analysis. Setting up a good gradient often poses a challenge, but the "iuvo” plates eradicate this issue. The Acumen offers a fast and accurate analysis of the chemotaxis assay and whole well scanning enables multiple cell movements to be captured and analyzed within any one well.”

Related Links:
TTP LabTech
BellBrooks Labs




Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.